TY - JOUR
T1 - Assessing the Validity and Reliability of the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire Among Children With Uveitis
AU - Cassedy, Amy
AU - Altaye, Mekibib
AU - Andringa, Jennifer
AU - Cooper, Ashley M.
AU - Drews-Botsch, Carolyn
AU - Engelhard, George
AU - Hennard, Theresa
AU - Holland, Gary N.
AU - Jenkins, Kirsten
AU - Lambert, Scott R.
AU - Lipscomb, Jessi
AU - McCracken, Courtney
AU - McCurdy, Deborah K.
AU - McDonald, Joseph
AU - Mwase, Najima
AU - Prahalad, Sampath
AU - Stahl, Erin
AU - Utz, Virginia Miraldi
AU - Walker, A. Adrienne
AU - Yeh, Steven
AU - Angeles-Han, Sheila T.
N1 - Publisher Copyright:
© 2020 American College of Rheumatology.
PY - 2022/3
Y1 - 2022/3
N2 - Objective: The Effects of Youngsters’ Eyesight on Quality of Life (EYE-Q) questionnaire measures vision-related functioning (VRF) and vision-related quality of life (VRQoL) in children with uveitis. Our aim was to revise the alpha version of the EYE-Q to refine VRF and VRQoL subscales and to assess the validity of the EYE-Q. Methods: Children with juvenile idiopathic arthritis (JIA), JIA-associated uveitis, and other noninfectious uveitis were enrolled. Patients and parents completed the EYE-Q, Pediatric Quality of Life Inventory (overall quality of life), and Childhood Health Assessment Questionnaire (physical functioning). The development site completed the alpha version of the EYE-Q, and the composite sites completed the beta version. We compared item-subscale correlations, internal consistency, and construct and discriminant validity among the different versions. Results: Of the 644 patients enrolled, 61.6% completed the alpha version, and 38.4% the beta version of the EYE-Q. Mean ± SD patient age was 11.1 ± 4.2 years, and 70% were female. Fewer White patients (73.5%) completed the alpha version compared to the beta version (86.2%; P < 0.001). With the exception of patient-reported VRF, both versions had similar item-subscale correlations. Version comparisons on scale internal consistencies indicated significant differences for parent- and patient-reported VRF, but each scale had a Cronbach's α of >0.80 beta. When data were combined, the EYE-Q showed significant differences between JIA-only and uveitis patients on all parent and patient scores, except for patient-reported VRF. Conclusion: The EYE-Q appears to be a valid measure of VRF and VRQoL in pediatric uveitis. Our results suggest it may be used as an outcome measure in multicenter pediatric uveitis studies.
AB - Objective: The Effects of Youngsters’ Eyesight on Quality of Life (EYE-Q) questionnaire measures vision-related functioning (VRF) and vision-related quality of life (VRQoL) in children with uveitis. Our aim was to revise the alpha version of the EYE-Q to refine VRF and VRQoL subscales and to assess the validity of the EYE-Q. Methods: Children with juvenile idiopathic arthritis (JIA), JIA-associated uveitis, and other noninfectious uveitis were enrolled. Patients and parents completed the EYE-Q, Pediatric Quality of Life Inventory (overall quality of life), and Childhood Health Assessment Questionnaire (physical functioning). The development site completed the alpha version of the EYE-Q, and the composite sites completed the beta version. We compared item-subscale correlations, internal consistency, and construct and discriminant validity among the different versions. Results: Of the 644 patients enrolled, 61.6% completed the alpha version, and 38.4% the beta version of the EYE-Q. Mean ± SD patient age was 11.1 ± 4.2 years, and 70% were female. Fewer White patients (73.5%) completed the alpha version compared to the beta version (86.2%; P < 0.001). With the exception of patient-reported VRF, both versions had similar item-subscale correlations. Version comparisons on scale internal consistencies indicated significant differences for parent- and patient-reported VRF, but each scale had a Cronbach's α of >0.80 beta. When data were combined, the EYE-Q showed significant differences between JIA-only and uveitis patients on all parent and patient scores, except for patient-reported VRF. Conclusion: The EYE-Q appears to be a valid measure of VRF and VRQoL in pediatric uveitis. Our results suggest it may be used as an outcome measure in multicenter pediatric uveitis studies.
UR - http://www.scopus.com/inward/record.url?scp=85117237409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117237409&partnerID=8YFLogxK
U2 - 10.1002/acr.24491
DO - 10.1002/acr.24491
M3 - Article
C2 - 33085849
AN - SCOPUS:85117237409
SN - 2151-4658
VL - 74
SP - 355
EP - 363
JO - Arthritis care & research
JF - Arthritis care & research
IS - 3
ER -